Literature DB >> 26362309

Neprilysin Confers Genetic Susceptibility to Alzheimer's Disease in Han Chinese.

Hui-Zhen Wang1, Rui Bi1, Deng-Feng Zhang1,2, Guo-Dong Li1,2, Xiao-Hong Ma3, Yiru Fang4, Tao Li3, Chen Zhang4, Yong-Gang Yao5,6,7.   

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease, with increasing incidence all over the world. Amyloid-β (Aβ) was considered to be the original cause to AD, and many reported pathogenic or risk genes for AD were located in the Aβ generation and degradation pathways. Neprilysin (NEP), insulin-degrading enzyme (IDE), and matrix metalloprotease-9 (MMP-9) are the most important Aβ-degrading proteases. Accumulating genetic evidence suggested that single nucleotide polymorphisms (SNPs) of these genes confer susceptibility to AD in Caucasian populations. In this study, we screened eight SNPs within these three Aβ-degrading protease genes in 1475 individuals of two independent Han Chinese case-control cohorts. SNP rs1816558 of NEP was found to be significantly associated with AD after adjustment for ε4 allele of the apolipoprotein E gene (APOEε4) and the Bonferroni correction. The remaining variants were not associated with risk of AD in Han Chinese sample set. Further data mining revealed that messenger RNA (mRNA) level of NEP substantially increased during the development of AD and was positively correlated with APP expression. The combined results indicated that NEP confers genetic susceptibility to AD in Han Chinese populations.

Entities:  

Keywords:  Alzheimer’s disease; Aβ-degrading enzyme; Chinese; Genetic susceptibility; Neprilysin

Mesh:

Substances:

Year:  2015        PMID: 26362309     DOI: 10.1007/s12035-015-9411-z

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  61 in total

1.  Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease.

Authors:  R Abraham; A Myers; F Wavrant-DeVrieze; M L Hamshere; H V Thomas; H Marshall; D Compton; G Spurlock; D Turic; B Hoogendoorn; J M Kwon; R C Petersen; E Tangalos; J Norton; J C Morris; R Bullock; D Liolitsa; S Lovestone; J Hardy; A Goate; M O'Donovan; J Williams; M J Owen; L Jones
Journal:  Hum Genet       Date:  2001-11-01       Impact factor: 4.132

2.  Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.

Authors:  James Scott Miners; Zoë Van Helmond; Katy Chalmers; Gordon Wilcock; Seth Love; Patrick Gavin Kehoe
Journal:  J Neuropathol Exp Neurol       Date:  2006-10       Impact factor: 3.685

3.  Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy.

Authors:  Mélanie Carpentier; Yves Robitaille; Luc DesGroseillers; Guy Boileau; Mieczyslaw Marcinkiewicz
Journal:  J Neuropathol Exp Neurol       Date:  2002-10       Impact factor: 3.685

4.  Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40).

Authors:  J R Backstrom; G P Lim; M J Cullen; Z A Tökés
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

5.  Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.

Authors:  E Hellström-Lindahl; R Ravid; A Nordberg
Journal:  Neurobiol Aging       Date:  2006-11-13       Impact factor: 4.673

6.  Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease.

Authors:  Mia E-L Blomqvist; Peter A Silburn; Daniel D Buchanan; Niels Andreasen; Kaj Blennow; Nancy L Pedersen; Anthony J Brookes; George D Mellick; Jonathan A Prince
Journal:  Neurogenetics       Date:  2004-04-16       Impact factor: 2.660

7.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes.

Authors:  S Ghosh; R M Watanabe; T T Valle; E R Hauser; V L Magnuson; C D Langefeld; D S Ally; K L Mohlke; K Silander; K Kohtamäki; P Chines; J Balow; G Birznieks; J Chang; W Eldridge; M R Erdos; Z E Karanjawala; J I Knapp; K Kudelko; C Martin; A Morales-Mena; A Musick; T Musick; C Pfahl; R Porter; J B Rayman
Journal:  Am J Hum Genet       Date:  2000-10-13       Impact factor: 11.043

9.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

10.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.

Authors:  R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

View more
  10 in total

1.  The Arc Gene Confers Genetic Susceptibility to Alzheimer's Disease in Han Chinese.

Authors:  Rui Bi; Li-Li Kong; Min Xu; Guo-Dong Li; Deng-Feng Zhang; Tao Li; Yiru Fang; Chen Zhang; Buchang Zhang; Yong-Gang Yao
Journal:  Mol Neurobiol       Date:  2017-01-20       Impact factor: 5.590

Review 2.  Long-term neprilysin inhibition - implications for ARNIs.

Authors:  Duncan J Campbell
Journal:  Nat Rev Cardiol       Date:  2016-12-15       Impact factor: 32.419

3.  Genetic association of the cytochrome c oxidase-related genes with Alzheimer's disease in Han Chinese.

Authors:  Rui Bi; Wen Zhang; Deng-Feng Zhang; Min Xu; Yu Fan; Qiu-Xiang Hu; Hong-Yan Jiang; Liwen Tan; Tao Li; Yiru Fang; Chen Zhang; Yong-Gang Yao
Journal:  Neuropsychopharmacology       Date:  2018-07-06       Impact factor: 7.853

4.  Rare Genetic Variants of the Transthyretin Gene Are Associated with Alzheimer's Disease in Han Chinese.

Authors:  Qun Xiang; Rui Bi; Min Xu; Deng-Feng Zhang; Liwen Tan; Chen Zhang; Yiru Fang; Yong-Gang Yao
Journal:  Mol Neurobiol       Date:  2016-08-25       Impact factor: 5.590

5.  Tissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression.

Authors:  Ximena Leighton; Alakesh Bera; Ofer Eidelman; Lukas Bubendorf; Tobias Zellweger; Jaideep Banerjee; Edward P Gelmann; Harvey B Pollard; Meera Srivastava
Journal:  PLoS One       Date:  2018-10-15       Impact factor: 3.240

6.  Expression of Neprilysin in Skeletal Muscle by Ultrasound-Mediated Gene Transfer (Sonoporation) Reduces Amyloid Burden for AD.

Authors:  Yuanli Li; Yadi Wang; Jue Wang; Ka Yee Chong; Jingjing Xu; Zhaohui Liu; Chunlei Shan
Journal:  Mol Ther Methods Clin Dev       Date:  2020-01-10       Impact factor: 6.698

Review 7.  Neprilysin expression and functions in development, ageing and disease.

Authors:  N N Nalivaeva; I A Zhuravin; A J Turner
Journal:  Mech Ageing Dev       Date:  2020-09-26       Impact factor: 5.432

8.  The Association between Neprilysin gene polymorphisms and Alzheimer's disease in Tibetan population.

Authors:  Siwei Chen; Dunzhu Mima; Haiqiang Jin; Qu Dan; Fei Wang; Juan Cai; Lin Shi; Huali Wang; Ailian Du; Ying Tang; Yongan Sun
Journal:  Brain Behav       Date:  2020-12-13       Impact factor: 2.708

Review 9.  Modelling Sporadic Alzheimer's Disease Using Induced Pluripotent Stem Cells.

Authors:  Helen A Rowland; Nigel M Hooper; Katherine A B Kellett
Journal:  Neurochem Res       Date:  2018-11-01       Impact factor: 3.996

10.  Association of Genes Involved in the Metabolic Pathways of Amyloid-β and Tau Proteins With Sporadic Late-Onset Alzheimer's Disease in the Southern Han Chinese Population.

Authors:  Xuewen Xiao; Bin Jiao; Xinxin Liao; Weiwei Zhang; Zhenhua Yuan; Lina Guo; Xin Wang; Lu Zhou; Xixi Liu; Xinxiang Yan; Beisha Tang; Lu Shen
Journal:  Front Aging Neurosci       Date:  2020-11-06       Impact factor: 5.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.